As of 2026-06-07, the Relative Valuation of Rapt Therapeutics Inc (RAPT) is (59.04) USD. This relative valuation is based on P/E multiples. With the latest stock price at 58.02 USD, the upside of Rapt Therapeutics Inc based on Relative Valuation is -201.8%.
The range of the Relative Valuation is (54.86) - (63.22) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 15.1x - 17.4x | 16.2x |
| Forward P/E multiples | 13.1x - 19.4x | 16.2x |
| Fair Price | (54.86) - (63.22) | (59.04) |
| Upside | -194.6% - -209.0% | -201.8% |
| Date | P/E |